The post $500 a Month in These Stocks Will Generate $6,700 in Passive Annual Income appeared first on 24/7 Wall St..
Passive income is the paycheck that arrives whether you show up or not. Wages depend on a functioning employer, a healthy economy, and the continued willingness of both to keep the seat warm. Dividend income depends on a company writing a check every 90 days, and for a handful of blue chips, that check has arrived without interruption for more than half a century.
Real estate can deliver similar cash flow, but it comes with tenants, repairs, and closing costs measured in weeks. High-yield dividend stocks settle in seconds, can be sold in any size, and require no phone calls at midnight. For an income-focused investor, that liquidity premium is often worth more than the last basis point of yield.
We screened our 24/7 Wall St. dividend equity research database, looking for stocks that pay massive dividends, and we found a collection of companies that, combined, can generate over $6,700 a year in passive annual income if you invest just $50,000 in each stock at the time of this writing.
Johnson & Johnson (NYSE:JNJ) is a $611 billion diversified healthcare business split across Innovative Medicine (oncology franchises like DARZALEX, TREMFYA, and CARVYKTI) and MedTech (Cardiovascular, Orthopaedics, Surgery, and Vision).
The company generated $24.06 billion in Q1 2026 revenue, up 9.9% year over year, and raised full-year guidance to $100.3 billion to $101.3 billion in sales.
The yield sits on the lower end of this list because the underlying business is a triple-A cash machine. That said, JNJ raised its quarterly payout 3.1% to $1.34 per share in Q1, extending its streak to 64 consecutive years of dividend increases, the longest track record in big pharma. Institutions own 76.83% of the float, led by Vanguard, BlackRock, and State Street.
PepsiCo (NASDAQ:PEP) is the global snacks-and-beverages operator behind Pepsi, Lay’s, Doritos, Gatorade, Mountain Dew, Quaker, Cheetos, Tropicana, and poppi, split across six reporting segments. Q1 2026 revenue came in at $19.44 billion with core EPS of $1.61, beating consensus by 4.26%.
The yield has drifted higher on multi-quarter share-price weakness. Management just pushed the annualized dividend 4% higher to $5.92 per share starting with the June 2026 payment, the 54th consecutive annual increase, and authorized a new $10 billion share repurchase program through February 28, 2030.
FY26 cash returns are guided to $8.9 billion. Institutions hold 80.92% of shares, with Vanguard and BlackRock again the largest holders.
Pfizer (NYSE:PFE) is a global biopharma running three commercial engines: Primary Care (Eliquis, Prevnar, Nurtec ODT, Abrysvo), Oncology (Ibrance, Padcev, Xtandi, Lorbrena, plus the Seagen assets), and Specialty Care (the Vyndaqel family). Q1 2026 revenue reached $14.45 billion, up 5.4% year over year, with adjusted EPS of $0.75 topping estimates.
The elevated yield reflects the post-COVID revenue reset from Comirnaty and Paxlovid. Management is prioritizing the payout and deleveraging over buybacks: $3.3 billion in repurchase authorization remains untouched with none planned for 2026.
The quarterly is $0.43 per share, held steady across 8 consecutive quarters, and the Vyndamax patent settlement extends U.S. exclusivity to June 2031.
Combined, these 3 positions generate $6,753 in annual passive income on a $150,000 investment, a blended yield of 4.50%. Pfizer contributes $3,601, PepsiCo adds $2,097, and Johnson & Johnson rounds out the portfolio with $1,055.
24/7 Wall St.
| Ticker | Annual Income | Share of Total |
|---|---|---|
| PFE | $3,601 | 53.3% |
| PEP | $2,097 | 31.1% |
| JNJ | $1,055 | 15.6% |
| Total | $6,753 | 100% |
Reinvest every distribution rather than spending it, and the share count grows quarter after quarter without a single additional dollar of fresh capital. That compounding is what separates a dividend portfolio from a bond ladder: the coupon size expands on its own. For investors building toward a future income floor, three checks a year from three separate industries is a durable place to start.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Johnson & Johnson didn’t make the cut. Grab the names FREE today.
The post $500 a Month in These Stocks Will Generate $6,700 in Passive Annual Income appeared first on 24/7 Wall St..


